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OBJECTIVES The aim of this study was to determine the changes in sympathetic nerve activity (SNA) after
atrioventricular junction (AVJ) ablation in patients with chronic atrial fibrillation (AF).
BACKGROUND Polymorphic ventricular tachycardia (PMVT) has been reported after AVJ ablation in
patients paced at a rate of #70 beats/min. We hypothesized that AVJ ablation results in
sympathetic neural changes that favor the occurrence of PMVT and that pacing at
90 beats/min attenuates these changes.
METHODS Sympathetic nerve activity, 90% monophasic cardiac action potential duration (APD90), right
ventricular effective refractory period (ERP) and blood pressure measurements were obtained
in 10 patients undergoing AVJ ablation. Sympathetic nerve activity was analyzed at baseline
and during and after successful AVJ ablation for at least 10 min. Data were also collected after
ablation at pacing rates of 60 and 90 beats/min. The APD90 and ERP were measured before
and after AV block during pacing at 120 beats/min.
RESULTS Sympathetic nerve activity increased to 134 6 16% of the pre-ablation baseline value (p ,
0.01) after successful AVJ ablation plus pacing at 60 beats/min and decreased to 74 6 8% of
baseline (p , 0.05) with subsequent pacing at 90 beats/min. Both APD90 and ERP increased
significantly.
CONCLUSIONS 1) Ablation of the AVJ followed by pacing at 60 beats/min is associated with an increase in
SNA. 2) Pacing at 90 beats/min decreases SNA to or below the pre-ablation baseline value.
3) Cardiac APD and ERP increase after AVJ ablation. The increase in SNA, along with the
prolongation in APD, may play a role in the pathogenesis of ventricular arrhythmias that
occur after AVJ ablation. (J Am Coll Cardiol 2000;36:151–8) © 2000 by the American
College of Cardiology
Catheter ablation of the atrioventricular junction (AVJ)
with implantation of a ventricular pacemaker is now an
acceptable treatment option in the management of drug-
refractory atrial fibrillation (AF). This procedure was first
performed using direct current energy, which resulted in
several complications, including ventricular fibrillation (VF)
(1,2). Currently, radiofrequency (RF) energy is the method
of choice because it is less painful and delivers a smaller,
more homogeneous lesion that is considered to be safer.
Ventricular fibrillation and sudden death, however, continue
to be reported in up to 7% of patients undergoing this
procedure, suggesting that factors other than the method of
AVJ ablation can play a role in the occurrence of these
ventricular arrhythmias (2–5).
Since the original observation of VF after AVJ ablation,
several reports have indicated that the arrhythmia seemed to
be pause- and bradycardia-dependent (4,5). Geelen et al. (5)
recently reported a decrease in the incidence of VF or
sudden death with high rate ventricular pacing. Ventricular
fibrillation or sudden death occurred in 6% of patients paced
at a rate of #70 beats/min after the procedure, compared
with 0% in those paced at a rate of 90 beats/min for one to
three months. The authors concluded that the occurrence of
this malignant ventricular arrhythmia might be prevented
with such a period of rapid pacing. The purpose of this
study was to investigate the sympathetic neural changes that
accompany AVJ ablation. We hypothesized that changes in
sympathetic nerve activity (SNA), either directly, associated
with AVJ ablation or indirectly, in response to hemody-
namic changes, enhance the risk of sudden cardiac death,
and that pacing at 90 beats/min attenuates these changes.
To test this hypothesis, muscle SNA, evaluated by micro-
neurography, monophasic cardiac action potential duration
(APD) and effective refractory period (ERP) were measured
in patients undergoing AVJ ablation for drug-refractory AF.
METHODS
Study patients. The study was performed at the Dallas
Veterans Affairs Medical Center. Written, informed con-
sent was obtained from all patients, and the procedures were
in accordance with institutional guidelines. All patients with
drug-refractory chronic AF referred for AVJ ablation were
screened for the study. Patients were excluded if they had a
history of insulin-dependent diabetes mellitus or a history or
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signs of peripheral neuropathy. A total of 12 patients were
enrolled, and successful muscle SNA recordings were ob-
tained in 10 patients. In the remaining two patients,
peroneal nerve recordings were technically difficult and
could not be obtained. The data on the 10 patients in whom
the experimental protocol was conducted comprise the
material of this study.
Electrophysiologic study. Patients were studied in the
drug-free, postabsorptive state after informed consent was
obtained. In patients receiving beta-blocker therapy, these
drugs were discontinued at least five half-lives before the
study. Local anesthesia was achieved with 2% procaine
hydrochloride, and conscious sedation was avoided, if pos-
sible, until the end of the research protocol. In patients who
needed sedation, intravenous midazolam was given at the
beginning of the study before any baseline measurements
were made. Central venous access was obtained from the
femoral veins, and continuous arterial blood pressure (BP)
monitoring was obtained from a 5F catheter positioned in
the right femoral artery. One quadripolar catheter was
inserted percutaneously and positioned in the right ventric-
ular (RV) apex. A monophasic action potential (MAP)
catheter (EP Technologies, Sunnyvale, California) was
placed in the RV apex on the interventricular septum.
Ventricular pacing thresholds were then measured from
both catheters. When APD and ERP were being measured,
pacing was always performed from the MAP catheter; all
other pacing was performed from the RV catheter. Radio-
frequency ablation was performed using a 5-mm tip catheter
(EP Technologies). The end point of ablation was complete
AV block that persisted at least 30 min.
Experimental protocol. Muscle SNA, arterial pressure and
MAP signals were recorded continuously throughout the
protocol. At least 5 min of baseline AF was recorded before
the first RF ablation attempt. Radiofrequency ablation was
performed as many times as necessary until successful
ablation was accomplished (producing sustained AV block).
A new baseline was recorded for at least 1 min before each
RF application. The baseline value preceding the successful
ablation was compared with the initial baseline value, and all
physiologic measures were not significantly different (p .
0.46); therefore, the baseline values preceding ablation were
used for all analyses. Once AV block was achieved, RV
pacing was performed at 60 beats/min for 10 min. This was
followed by pacing at 90 beats/min for 2 min. Arterial
pressure and SNA data were averaged over a 1-min period
before ablation (baseline), during the first and tenth minutes
after AV block while pacing at 60 beats/min and during the
second minute of pacing at 90 beats/min. During AF, the
diastolic and systolic pressures were defined on the basis of
whether a given QRS complex produced a significant
pressure pulse (increase of .10 mm Hg). In each patient,
the average values during AF were obtained from at least 70
heart beats. In addition, physiologic and MAP data were
obtained during RV pacing at 120 beats/min for 1 min
before and after AV block. Pacing at 120 beats/min after
AV block was performed ;20 min after successful AVJ
ablation. The APD90 (defined subsequently) and ERP at a
pulse width of 2 ms and at twice the diastolic threshold
were obtained from the MAP catheter recordings. A rate of
120 beats/min was chosen to avoid competition during AF
before ablation. The MAP recordings were obtained at the
beginning of the study. If the MAP tracing changed during
the study, the catheter was gently advanced to improve the
signal. If the signal failed to improve and required reposi-
tioning of the catheter, the data were disregarded because
comparison with baseline values was no longer feasible.
Measurements. Efferent, postganglionic muscle SNA was
recorded from the right peroneal nerve, as described previ-
ously (6). Quantitation of SNA was assessed as the sum of
the area of SNA bursts/10 s. These values were derived from
1-min sampling periods and extrapolating to activity/10 s by
dividing by 6. For each 1-min sampling period, data were
quantified in consecutive 10-s sampling epochs, and analysis
of variance with repeated measures was performed to ensure
that SNA did not change significantly during the 1-min
sampling period, and this was confirmed for all measure-
ment periods. Burst area was used because it more appro-
priately reflects the changes in SNA, often producing broad,
irregular bursts of SNA associated with wide fluctuations in
arterial pressure during AF or rapid ventricular pacing.
Sympathetic nerve activity during pacing at 60 and
90 beats/min was reported as the percent baseline value
during AF before RF ablation (i.e., baseline SNA during
AF was reported as 100%). Arterial BP was directly re-
corded with a catheter inserted into the right femoral artery.
Heart rate (HR) was derived from continuous electrocar-
diographic recording of at least two leads (II and V1). We
measured APD90, defined as the action potential duration at
90% repolarization, from the MAP catheter during pacing
at 120 beats/min before and after ablation. The APD90 was
derived from the average of 10 consecutive heart beats for
each subject. The ERP was measured from the MAP
catheter as the longest coupling interval at which a ventric-
ular premature stimulus failed to capture twice after an
eight-beat drive train.
Follow-up. After the procedure, all patients underwent
implantation of a permanent pacemaker, except for one
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patient who already had a pacemaker implanted for symp-
tomatic bradycardia. They were then admitted to a telem-
etry unit for at least 24 h and discharged at a heart rate of
90 beats/min. Follow-up was done at one week, six weeks
and every three months thereafter. The pacing rate was
decreased to 70 beats/min after six weeks for the remaining
duration of the follow-up period.
Statistical analysis. All data were processed to produce
mean values for the last 30-s segments of each phase of the
protocol. All data sets were normally distributed, as deter-
mined by a Kolmogorov-Smirnov test. Comparisons of the
effect of RF ablation on all variables were performed using
analysis of variance with repeated measures. When a main
effect difference was observed, a post hoc evaluation was
performed with a least significant difference test. Compar-
isons of the responses to pacing at 120 beats/min before and
after ablation, as well as between postablation pacing at 60
and 90 beats/min, were performed with a paired t test. All
significant differences reflect a p value , 0.05.
RESULTS
Patient characteristics. All patients were men (mean age
61 6 11 years). Left ventricular function was normal in six
patients, moderately depressed in one and severely de-
pressed in three. The mean average HR before RF ablation
was 92 6 5 beats/min. Successful RF ablation of the AVJ
using the right-sided approach was accomplished in all
patients. The median number of RF lesions applied per
patient was four. A junctional escape rhythm with a rate of
,60 beats/min was noted after ablation in two patients. A
summary of the clinical characteristics and number of RF
lesions applied is provided in Table 1.
Effect of RF ablation without AV block. Successful AVJ
ablation was achieved on the first attempt in two patients. In
the other eight patients, a total of 10 RF lesions were
applied to the anteroseptal region, with a good temperature
rise but no AV block. These unsuccessful RF applications
had no effect on SNA, HR or arterial BP, as illustrated in
the sample tracing in Figure 1 and as summarized in Table
2.
Sympathetic nerve activity and arterial pressure after
successful AVJ ablation. A typical SNA and BP response
associated with successful AVJ ablation plus pacing at
60 beats/min is shown in Figure 2. A summary of the SNA
and BP changes is provided in Figure 3. For these analyses,
SNA is reported as the percent baseline value during AF
before RF ablation. In all patients, SNA increased signifi-
cantly during the first minute after successful AVJ ablation
plus pacing at 60 beats/min (DSNA 5 134 6 16%, p ,
0.01). This increase in SNA was sustained for the entire
duration of the nerve recording period after successful
ablation (20 to 45 min). A small drop in arterial BP
accompanied the increase in SNA, with a gradual recovery
to baseline.
Effect of pacing rate on SNA and arterial pressure after
successful AVJ ablation. Ten minutes after successful AVJ
ablation, the effect of pacing at 90 beats/min was compared
with the effect of pacing at 60 beats/min (Fig. 4). At this
time, SNA during pacing at 60 beats/min remained elevated
from the preablation baseline value (126 6 16%), but
decreased significantly below the preablation baseline value
during pacing at 90 beats/min (74 6 8%). Thus, pacing at
90 beats/min resulted in a decrease in SNA that was
significant relative to both pacing at 60 beats/min and the
preablation baseline value. The BP response was in the
opposite direction. Diastolic and mean arterial pressure
increased from 77 6 5 and 99 6 7 mm Hg during pacing
at 60 beats/min to 85 6 6 and 105 6 8 mm Hg during
pacing at 90 beats/min, respectively. These findings are
summarized in Figure 4.
Changes in APD and ERP after successful AVJ ablation.
Stable MAP recordings throughout the entire study were
available in six patients. In the remaining four patients, the
tracings changed during the study (decrease in amplitude
and unstable diastolic baseline values), making the measure-
ments unreliable. Therefore, APD90 was measured before
and ;20 min after successful AVJ ablation during pacing at
a rate of 120 beats/min in six patients. The APD90 increased
in every patient (242 6 17 ms before ablation vs. 261 6
12 ms after ablation, p , 0.01). Similarly, the ERP at a
pacing rate of 120 beats/min increased significantly after













1 56 .50% None 9 Digoxin No
2 72 .50% Trac 4 Digoxin, metoprolol No
3 71 .50% None 4 Digoxin, diltiazem No
4 58 .50% Trace 2 Digoxin, metoprolol No
5 46 .50% Trace 2 Metoprolol, amiodarone Yes
6 67 20% Moderate 10 Digoxin Yes
7 69 20% Mild 5 Digoxin, metoprolol Yes
8 42 .50% None 5 Digoxin, verapamil Yes
9 68 35% Mild 3 Digoxin, metoprolol Yes
10 61 20% Mild 3 Digoxin, metoprolol Yes
EF 5 ejection fraction; MAP 5 monophasic action potential; RFA 5 radiofrequency ablation.
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ablation (215 6 14 ms before ablation vs. 233 6 16 ms after
successful AVJ ablation, p , 0.01) (Fig. 5). Blood pressure
and SNA, however, did not change significantly during
pacing at 120 beats/min before and after ablation. A
summary of the APD and ERP changes is provided in
Table 3.
Follow-up. During a mean follow-up period of 9.5 6 5
months, all patients did well, except for one who presented
with multiple episodes of polymorphic ventricular tachycar-
dia (PMVT) soon after the procedure. This particular
patient had a history of sustained monomorphic ventricular
tachycardia requiring placement of an implantable
cardioverter-defibrillatory 10 months before his AVJ abla-
tion. The episodes of PMVT were treated with beta-
blockers and by increasing the pacing rate to 100 beats/min
for 24 h. Several weeks after hospital discharge, the patient
died at home. A postmortem device interrogation and
autopsy were not performed.
DISCUSSION
The main findings of this study are: 1) AVJ ablation
followed by pacing at 60 beats/min is associated with an
increase in SNA; 2) pacing at 90 beats/min decreases SNA;
and 3) APD and ERP in the RV apex are prolonged after
AVJ ablation. To our knowledge, this is the first study in
which SNA was measured directly during RF ablation. The
increase in SNA at 60 beats/min and the prolongation of
APD may predispose patients to early afterdepolarizations
and PMVT, known complications of AVJ ablation. The
decrease in SNA with pacing at 90 beats/min compared to
60 beats/min may contribute to the lower incidence of
PMVT in patients paced at faster rates.
Hemodynamic changes after AVJ ablation. Radiofre-
quency ablation of the AVJ has been shown to improve the
quality of life in patients with drug-refractory AF (7–9).
Although several studies indicate improvement in left ven-
tricular function after AVJ ablation (1,10–13), some authors
have reported no change or even hemodynamic deteriora-
tion at follow-up (8,14,15). Vanderheyden et al. (15) ob-
served hemodynamic deterioration related to worsening
mitral regurgitation in 7.4% of patients undergoing AVJ
ablation. Brignole et al. (14) recently reported that although
symptoms improved with AVJ ablation and pacemaker
implantation, cardiac performance, as evaluated by standard
echocardiography and exercise testing, remained stable over
time.
In the present study, we observed a subtle decrease in the
mean and diastolic arterial pressure initially after AV block,
but this pressure recovered to pre–RF ablation levels within
10 min in all patients. We did not measure cardiac output or
assess left ventricular function immediately after ablation,
but we believe that the decrease in BP after AV block can be
explained by the negative hemodynamic effect of RV apex
pacing and the decrease in ventricular rate. Right ventricular
apex pacing results in aberrant activation of the papillary
muscle, which may lead to mitral regurgitation (9). In
Figure 1. Sample tracings of integrated SNA, femoral artery pressure and ablation catheter. These tracings show a 20-s period before the onset of RF
ablation (RFA) and ;40 s of RF ablation without AV block. The arrow indicates the onset of RF ablation. No significant changes in arterial pressure or
SNA were produced by unsuccessful RF ablation (see Table 2).











Baseline 83 6 4 140 6 7 101 6 4 92 6 5 100 6 0
RFA, no
block
79 6 4 142 6 9 100 6 6 87 6 7 93 6 14
Data are presented as the mean value 6 SEM.
DBP 5 diastolic blood pressure; HR 5 heart rate; MBP 5 mean blood pressure;
RFA 5 radiofrequency ablation, SBP 5 systolic blood pressure; SNA 5 sympathetic
nerve activity.
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addition, the altered sequence of activation associated with
RV pacing results in changes in coronary blood flow and
elevation in tissue catecholamine levels, which can all lead to
a negative effect on left ventricular function (14).
Changes in SNA after AVJ ablation. Unsuccessful RF
energy delivery at the AVJ had no effect on SNA, HR or
BP. This was true of RF attempts that produced sustained
elevations of temperature. Therefore, neither the acute
Figure 2. Sample tracings of integrated SNA, femoral artery pressure and surface ECG for one patient. The periods shown include a baseline period (during
AF) just before the beginning of RF ablation and during RF ablation (arrow on ECG panel) in which AV block was achieved within 10 s, 10 min after
AV block (pacing at 60 beats/min) and 12 min after AV block (pacing at 90 beats/min).
Figure 3. Mean (6SEM) arterial pressures and SNA levels for all 10
patients at baseline (with atrial fibrillation [AFib]), during RF ablation
(RFA) with AV block (first minute) and 10 min after AV block was
achieved. Asterisks indicate significant differences from baseline (p ,
0.05).
Figure 4. Mean (6SEM) arterial pressures and SNA levels for all 10
patients during pacing rates of 60 and 90 beats/min after complete AV
node block was achieved by RF ablation. The data for pacing at 60
beats/min were collected immediately before pacing at 90 beats/min.
Asterisks indicate significant differences between pacing rates (p , 0.05).
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application of RF energy nor the resulting lesion that was
presumably produced appeared to affect basal SNA or
hemodynamic conditions. However, when AV block was
achieved and pacing was performed at 60 beats/min, SNA
increased significantly above the preablation baseline value
during AF (by ;30%). This was associated with a small, but
significant decrease in mean and diastolic BP, suggesting
that the sympathoexcitation was partly due to a reflex-
mediated effect. However, the elevation of SNA persisted
throughout the postablation period of measurement, despite
a return of both mean and diastolic BP to preablation levels.
This may reflect that baroreflex-mediated sympathoexcita-
tion adequately corrected the modest hypotension after
successful ablation; however, other explanations may also be
involved. A direct effect of RV pacing on cardiopulmonary
receptors is a possible explanation that we think is very
unlikely. Smith et al. (16) have shown that RV pacing
produces similar hemodynamic and SNA responses to
spontaneous ventricular tachycardia of the same rate. Direct
activation of SNA by a small cardiac lesion could occur as a
result of disruption of cardioinhibitory afferent signals,
resulting in sympathoexcitation. Although this scenario is
possible, we believe this is unlikely because of the size of the
lesion. Another possible related mechanism could be a
change in cardiac filling pressures—the stimulus for cardio-
pulmonary baroreceptors. We did not measure intracardiac
pressures during this study because of the required addi-
tional venous access and the risk of dislodging the tempo-
rary pacemaker during manipulation of the pulmonary
artery catheter. However, the hemodynamic effects of AF
and ventricular pacing at 60 beats/min after AVJ ablation
have been reported: Clark et al. (17) showed no significant
change in right atrial and pulmonary capillary wedge pres-
sures in patients with AF after AVJ ablation and pacing at
60 beats/min. Blood pressure fluctuations during AF are
variable and include periodic, large elevations, as shown in
Figure 1. Because all the patients studied had very high
basal SNA, these periodic increases in arterial pressure tend
to inhibit SNA. Therefore, successful AVJ ablation may
serve to stabilize these arterial pressure fluctuations, so that
the patient’s high basal SNA is allowed to run uninhibited.
This is consistent with preliminary data from our group
suggesting that the net SNA response to high rates of
ectopy (e.g., bigeminy) is a reduction in SNA in patients
with very high basal SNA, which is in contrast to a normal
increase in SNA during high rates of ectopy in most patients.
When the postablation ventricle was paced at 90 beats/
min, mean and diastolic BPs were increased significantly,
compared with pacing at 60 beats/min, and this resulted in
a reflex-mediated decrease in SNA. This decrease in SNA
was to a level that was below the preablation baseline levels
during AF. These data show that one of the hemodynamic
benefits of an elevated pacing rate is a reduction in the
chronically elevated SNA level, not only in relation to
postablation pacing at 60 beats/min but also in relation to
the preablation state. The potential clinical relevance of
these findings are discussed subsequently.
Alterations in autonomic innervation after RF ablation.
Several authors have described an increase in the sinus rate
after ablation of para-Hisian accessory pathways (18), after
AV node modification using the posterior approach and
after ablation of posteroseptal accessory pathways (19–21).
In an effort to investigate the autonomic changes that follow
RF ablation, analysis of HR variability has been used
Figure 5. Monophasic action potential recordings obtained from the MAP
catheter positioned at the RV apex during pacing at 120 beats/min. Top,
Before ablation, APD90 was 229 ms and ERP was 200 ms, with evidence
of capture at a coupling interval equal to 210 ms. Bottom, After ablation,
APD90 increased to 258 ms and premature stimuli delivered at a coupling
interval of 220 ms failed to capture. The ERP increased from 200 ms
before ablation to 220 ms after ablation.













Before RF ablation 242 6 17 215 6 14 133 6 14 79 6 7 97 6 10 642 6 59
After AV block 261 6 12 233 6 16 136 6 16 81 6 8 99 6 11 621 6 48
p Value , 0.01 , 0.01 NS NS NS NS
Data are presented as the mean value 6 SEM.
APD90 5 duration of action potential at 90% repolarization; AV 5 atrioventricular; ERP 5 effective refractory period; NS 5
not significant; RF 5 radiofrequency; other abbreviations as in Table 2.
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(19,20). Most of these studies revealed a significant reduc-
tion in the high frequency components of the HR frequency
spectra, indicating that parasympathetic denervation of the
sinus node may have occurred, which was then reversed
within one to six months, suggesting that reinnervation may
have occurred. Although most of these studies suggested
parasympathetic denervation, some data were also sugges-
tive of sympathetic denervation (19–22).
In our study, we could not use measures of HR variability
owing to the presence of AF and postablation complete AV
block. Therefore, we used cardiac electrophysiologic prop-
erties to assess changes in cardiac autonomic function. We
demonstrated an increase in right ventricular APD and
ERP after successful AVJ ablation. These findings were
present in every patient, and the changes reached statistical
significance. In our opinion, this could be explained by
downstream myocardial denervation. Transmural myocar-
dial infarction has been shown to interrupt sympathetic and
vagal transmission over axons located within the region of
infarction and produce “downstream” sympathetic and vagal
denervation at non–infarct-related sites apical to the infarc-
tion (23,24). If RF ablation results in myocardial denerva-
tion, our findings of prolonged RV APD and ERP would
suggest predominance of sympathetic innervation. Another
possible explanation for the APD and ERP prolongation
after AVJ ablation may be the effect of sustained tachycardia
during AF on ventricular refractoriness. Recently, Krebs et
al. (25) demonstrated, for the first time in humans, that
short-term rapid ventricular pacing prolongs ventricular
refractoriness. In patients with poorly controlled AF, you
would expect the tachycardia-induced changes in ventricular
refractoriness to be present even before AVJ ablation. In our
study, we found a change in APD and ERP after AV block.
Therefore, unless tachycardia-induced changes in ventricu-
lar refractoriness manifest only after slowing of the heart
rate, we find it hard to explain our results with the latter
hypothesis.
Ventricular arrhythmias after AVJ ablation. Ventricular
fibrillation was reported after RF ablation and was attrib-
uted to the slow HR associated with AV block. Interest-
ingly, patients with AF and spontaneous AV block, paced at
60 beats/min, do not experience a similar incidence of
sudden death. In this latter group, we think the decrease in
HR is gradual, and as such, these patients are less likely to
have acute hemodynamic, neural and electrophysiologic
changes. In addition, one cannot exclude a proarrhythmic
effect of the RF ablation itself, as previously discussed. In
our present study, one patient of 10 had frequent episodes of
PMVT two weeks after the procedure. It is conceivable that
these episodes had nothing to do with the procedure.
However, the presence of only one event before AVJ
ablation, the occurrence of .20 episodes after the procedure
and the mode of initiation (long–short) with every episode
suggest that this was a complication.
Clinical implications. Our findings help explain the
mechanism responsible for malignant ventricular arrhyth-
mias after AVJ ablation. The increase in SNA in the setting
of prolonged APD creates a milieu that favors early after-
depolarizations and triggered activity, which can result in
PMVT, a known complication of AVJ ablation. The de-
crease in SNA and shortening of APD with rapid pacing
may also explain the lower incidence of PMVT with rapid
pacing. These results indicate that increased SNA may play
a role in the pathogenesis of PMVT, and that bradycardia is
not the only factor involved. In fact, if cardiac denervation
occurs after ablation, then the increase in SNA can be
potentially proarrhythmic in many ways, as denervated
tissue may become supersensitive to certain agents such as
catecholamines.
Study limitations. There are limitations of this study: 1)
We did not measure APD and ERP at 60 beats/min before
ablation, and therefore an increase in APD duration after
ablation at 60 beats/min can only be assumed to be true, on
the basis of measurements obtained at 120 beats/min. The
APD and ERP were not measured at 60 beats/min because
the ventricular response during AF was significantly higher
than 60 beats/min. 2) We did not assess the SNA response
during RF ablation at other sites to see whether the changes
were specific to anteroseptal ablation. Although this is true,
the lack of any change in SNA during unsuccessful ablation
indicates to us that the increase in SNA was secondary to
AV block and was not a direct effect of the RF lesions.
Thus, these unsuccessful lesions served as our control data.
3) We did not measure right and left atrial pressures during
the study. Although some authors have shown no change in
central venous pressure after AVJ ablation, changes in
cardiac filling pressures might have played a role by chang-
ing the input to the cardiopulmonary baroreceptors and
their modulation of SNA. 4) Finally, the number of patients
was small. However, the changes in this study were present
in every patient, were very consistent and were statistically
significant.
Reprint requests and correspondence: Dr. Mohamed H. Ham-
dan, Dallas Veterans Affairs Medical Center, Division of Cardi-
ology (111A), 4500 S. Lancaster Road, Dallas, Texas 75216.
E-mail: Hamdan@ryburn.swmed.edu.
REFERENCES
1. Evans GT Jr., Scheinman MM, Bardy G, et al. Predictors of
in-hospital mortality after DC catheter ablation of atrioventricular
junction: results of a prospective, international, multicenter study (see
comments). Circulation 1991;84:1924–37.
2. Olgin JE, Scheinman MM. Comparison of high energy direct current
and radiofrequency catheter ablation of the atrioventricular junction
(see comments). J Am Coll Cardiol 1993;21:557–64.
3. Evans GT, Scheinman MM. The percutaneous cardiac mapping and
ablation registry. Pacing Clin Electrophysiol 1988;11:1621–6.
4. Peters RH, Wever EF, Hauer RN, Wittkampf FH, Robles de Medina
EO. Bradycardia dependent QT prolongation and ventricular fibrilla-
tion following catheter ablation of the atrioventricular junction with
radiofrequency energy. Pacing Clin Electrophysiol 1994;17:108–12.
5. Geelen P, Brugada J, Andries E, Brugada P. Ventricular fibrillation
and sudden death after radiofrequency catheter ablation of the atrio-
ventricular junction. Pacing Clin Electrophysiol 1997;20:343–8.
157JACC Vol. 36, No. 1, 2000 Hamdan et al.
July 2000:151–8 Increased SNA After AVJ Ablation
6. Smith ML, Ellenbigen KA, Eckberg DL. Baseline arterial pressure
affects sympathoexcitatory responses to ventricular beats. Am J Physiol
1995;269:H153–9.
7. Jensen SM, Bergfeldt L, Rosenqvist M. Long-term follow-up of
patients treated by radiofrequency ablation of the atrioventricular
junction. Pacing Clin Electrophysiol 1995;18:1609–14.
8. Fitzpatrick AD, Kourouyan HD, Siu A, et al. Quality of life and
outcomes after radiofrequency His-bundle catheter ablation and per-
manent pacemaker implantation: impact of treatment in paroxysmal
and established atrial fibrillation. Am Heart J 1996;131:499–507.
9. Rosenquvist M, Lee MA, Moulinier L, et al. Long-term follow-up of
patients after transcatheter direct current ablation of the atrioventric-
ular junction. J Am Coll Cardiol 1990;16:1467–74.
10. Heinz G, Siostrzoneck P, Kreiner G, et al. Improvement in left
ventricular systolic function after successful ablation for drug refrac-
tory, chronic atrial fibrillation and recurrent atrial flutter. Am J Cardiol
1992;69:489–92.
11. Lemery R, Brugada P, Cheriex E, Wellens HJ. Reversibility of
tachycardia-induced left ventricular dysfunction after closed-chest
catheter ablation of the atrioventricular junction for intractable atrial
fibrillation. Am J Cardiol 1987;60:1406–8.
12. Brignole M, Gianfranchi L, Menozzi C, et al. Influence of atrioven-
tricular junction radiofrequency ablation in patients with chronic atrial
fibrillation and flutter on quality of life and cardiac performance. Am J
Cardiol 1994;74:242–6.
13. Geelen P, Goethals M, de Bruyne B, Brugada P. A prospective
hemodynamic evaluation of patients with chronic atrial fibrillation
undergoing radiofrequency catheter ablation of the atrioventricular
junction. Am J Cardiol 1997;80:1606–9.
14. Brignole M, Menozzi C, Gianfranchi L, et al. Assessment of atrio-
ventricular junction ablation and VVIR pacemaker versus pharmaco-
logical treatment in patients with heart failure and chronic atrial
fibrillation. Circulation 1998;98:953–60.
15. Vanderheyden M, Goethals M, Anguera I, et al. Hemodynamic
deterioration following radiofrequency ablation of the atrioventricular
conduction system. Pacing Clin Electrophysiol 1997;20:2422–8.
16. Smith M, Ellenbogen KA, Eckberg DL, Beightol LA. Human
sympathetic neural responses to induced ventricular tachycardia. J Am
Coll Cardiol 1991;18:1015–24.
17. Clark DM, Plumb VJ, Epstein AE, Kay GN. Hemodynamic effects of
an irregular sequence of ventricular cycle lengths during atrial fibril-
lation. J Am Coll Cardiol 1997;30:1039–45.
18. Pappone C, Stabile G, Oreto G, et al. Inappropriate sinus tachycardia
after radiofrequency ablation of para-hisian accessory pathways. J Car-
diovasc Electrophysiol 1997;8:1357–65.
19. Kocovic DZ, Harada T, Shea JB, et al. Alterations of heart rate and of
heart rate variability after radiofrequency catheter ablation of supraven-
tricular tachycardia. Circulation 1993;88:1671–81.
20. Frey B, Heinz G, Kreiner G, Schmidinger H, Weber H, Gossinger H.
Increased heart rate variability after radiofrequency ablation. Am J
Cardiol 1993;71:1460–1.
21. Geller C, Goette A, Carlson MD, et al. An increase in sinus rate
following radiofrequency energy application in the posteroseptal space.
Pacing Clin Electrophysiol 1998;21:303–7.
22. Psychari SN, Theodorakis GN, Koutelou M, Livanis EG, Kremasti-
nos DT. Cardiac denervation after radiofrequency ablation of su-
praventricular tachycardias. Am J Cardiol 1998;81:725–31.
23. Inoue H, Zipes DP. Time course of denervation of efferent sympa-
thetic and vagal nerves after occlusion of the coronary artery in the
canine heart. Circ Res 1988;62:1111–20.
24. Stanton MS, Tuli MM, Radtke NL. Regional sympathetic denerva-
tion following nyocardial infarction in humans detected non-invasively
using I-123 metaiodobenzylguanidine. J Am Coll Cardiol 1989;14:
1519–26.
25. Krebs ME, Szwed JM, Shinn T, Miles WM, Zipes DP. Short term
rapid ventricular pacing prolongs ventricular refractoriness in patients.
J Cardiovasc Electrophysiol 1998;9:1036–42.
158 Hamdan et al. JACC Vol. 36, No. 1, 2000
Increased SNA After AVJ Ablation July 2000:151–8
